As China's medical and healthcare industry is developing rapidly, the independent innovation and promotion application of high-end Medical Equipment has become a key part.

Recently, the National Health Commission released the "2024 High-end Medical Equipment Promotion Application Project Announcement", and the CGO-5200 series DSA products independently developed and produced by Beijing Wandong Medical Technology in the Midea Group Co., Ltd Medical Sector successfully made the list due to their excellent innovation and leading technology.

It is reported that the high-end Medical Equipment promotion application project is a collaborative effort by the General Administration of Industry and Information Technology and the National Health Commission, aimed at deeply implementing the Health China and manufacturing powerhouse strategic deployment. According to the requirements of the "14th Five-Year Plan" for the development of the Medical Equipment industry, it accelerates the advancement of innovation and promotion application of high-end Medical Equipment. This project focuses on typical application scenarios, mainly selecting projects that are at the forefront of technology innovation and clinical application levels in high-end Medical Equipment, which have strong leadership roles in collaborative innovation, pilot verification, clinical research, iterative upgrades, and promotion applications.

According to relevant personnel from Beijing Wandong Medical Technology, the selected CGO-5200 series not only meets all four requirements of the Ministry of Industry and Information Technology and the Health Commission, but also has achieved breakthroughs from technological innovation to clinical application. In terms of Hardware, it uses industry-leading ultra-micro dynamic flat panel detectors and high heat capacity tubes, continuously optimizing and improving image quality; in terms of Software, the CGO-5200Pro incorporates cutting-edge AI technology, deep learning, intelligent noise reduction, and integrated post-processing technology to achieve precise low-dose imaging. Innovative dual-axis acquisition, bracket refinement, 3D imaging, InvaRay CT, and other advanced features provide a series of solutions for vascular and non-vascular interventional surgeries involving neurology, peripheral procedures, oncology, and cardiology, meeting the national requirements for the intelligence and precision of high-end Medical Devices.

Beijing Wandong Medical Technology stated that this selection is inseparable from the company's continuous innovation and deep research and development accumulation. In particular, after joining Midea Group Co., Ltd, its own research and development strength and capability have rapidly escalated, while also collaborating with Midea Central Research Institute and Midea AI Research Institute for coordinated innovation, focusing on medium- and long-term common technologies, forward-looking technology research, and disruptive product platform innovation, which further consolidated the company's innovative foundation, and successively launched several original innovative products.

In the future, Beijing Wandong Medical Technology will continuously innovate and break through under the guidance of the Global Strategy of "product leadership, driven by digital intelligence", continuously promoting the empowerment of high-end state-owned medical devices for precise clinical care, injecting tremendous momentum into Health China.